Charles River Laboratories International (NYSE:CRL) Lifted to Buy at StockNews.com
StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a report issued on Thursday morning. Several other equities analysts also recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Charles River Laboratories International from $270.00 to $280.00 […]
More Stories
US Embassy Warns Americans to Reconsider Travel to Saudi Arabia Amid Houthi Strikes
By Jack Phillips The U.S. Embassy in Saudi Arabia’s capital on Tuesday issued renewed warnings about traveling to the country...
Pope Leo XIV Diagnosed With Cancer as Doctors Remove Part of His Lung
By Jill McLaughlin Pope Leo XIV was diagnosed with lung cancer following surgery to remove a section of his lung...
Third-Quarter Earnings Start This Week: Prepare for More Positive Surprises
By Louis Navellier Later this week, financial stocks will launch their third-quarter earnings season, and I expect most of the...
10 Most Anticipated Horror Games Coming Soon in 2026-2027
There is a bunching up of horror titles in the latter part of 2026 and the early months of 2027,...
Supreme Court to Hear Dispute Over Access to DOGE Records
By Matthew Vadum The Supreme Court on Oct. 13 agreed to decide whether a federal judge improperly ordered broad discovery...
Is Imperfect Women Season 2 Renewed?
Apple TV just dropped the most-awaited news for psychological thriller fans. Imperfect Women season 2 is happening. If you watched...